Skip to main content

Peer Review reports

From: The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence

Original Submission
27 Mar 2009 Submitted Original manuscript
12 May 2009 Reviewed Reviewer Report - Arndt Hartmann
14 May 2009 Reviewed Reviewer Report - Ergin Kilic
15 May 2009 Reviewed Reviewer Report - Peter Sinn
Resubmission - Version 2
Submitted Manuscript version 2
25 Nov 2009 Author responded Author comments - Douglas Ross
Resubmission - Version 3
25 Nov 2009 Submitted Manuscript version 3
16 Dec 2009 Reviewed Reviewer Report - Peter Sinn
4 Jan 2010 Reviewed Reviewer Report - Arndt Hartmann
28 Jan 2010 Author responded Author comments - Douglas Ross
Resubmission - Version 4
28 Jan 2010 Submitted Manuscript version 4
1 Feb 2010 Author responded Author comments - Douglas Ross
Resubmission - Version 5
1 Feb 2010 Submitted Manuscript version 5
10 Feb 2010 Author responded Author comments - Douglas Ross
Resubmission - Version 6
10 Feb 2010 Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
23 Feb 2010 Author responded Author comments - Douglas Ross
Resubmission - Version 8
23 Feb 2010 Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
8 Mar 2010 Author responded Author comments - Douglas Ross
Resubmission - Version 10
8 Mar 2010 Submitted Manuscript version 10
Publishing
22 Mar 2010 Editorially accepted
22 Mar 2010 Article published 10.1186/1471-2407-10-108

You can find further information about peer review here.

Back to article page